We evaluated the in vitro effects of AdipoRon, a small-molecule agonist analog of endogenous adiponectin, on U87 and SH-SY5Y cells, models of glial and neuronal cells, respectively, alone or in association with CSF from MS patients. Here, ADIPOQ is linked to myeloid sarcoma.